| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Accounting Officer | Chief Accounting Officer
1 company
Megna Michael R is a Chief Accounting Officer at KNSA. Recent filings cover 0 purchases and 15 sales. Those positions are worth an estimated $2.3M at current prices.
Our model assigns Megna Michael R a below-average insider score of 42/100, based on 12 past trades. Over a 12-month horizon, 20.0% of those trades were profitable, with an average 12-month return of -55.2%.
Megna Michael R's largest disclosed position is in KNSA as Chief Accounting Officer, worth about $2.3M. The recent filings there lean toward selling, a net 181,041 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Accounting Officer | Sale+OE | 16,670 | $19.17 | $319,563.90 | -49.5% | +6.3% | +7.6% | |
| Dec 19, 2023 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Accounting Officer | Sale+OE | 9,316 | $19.13 | $178,215.08 | -35.4% | +2.7% | +5.2% |